REQUEST A DEMO
Total
USD $0.00
Search more companies

Mega Lifesciences Sdn. Bhd. (Malaysia)

Main Activities: Nonstore Retailers | All Other Support Services | Administration of Public Health Programs
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Management of Companies and Enterprises
Full name: Mega Lifesciences Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

1. registered proprietor and marketer of healthcare products.2. provision of business support services to mega lifesciences pty ltd (thailand).3. engage in merchandising of neutraceutical and pharmaceutical products in the territory of malaysia.

Headquarters
B-28-02, The Ascent, The Paradigm, No.1, Jalan Ss7/26A, Kelana Jaya
Petaling Jaya; Selangor; Postal Code: 47301

Contact Details: Purchase the Mega Lifesciences Sdn. Bhd. report to view the information.

Website: http://www.megawecare.com.my

Basic Information
Outstanding Shares:
Purchase the Mega Lifesciences Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Mega Lifesciences Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Mega Lifesciences Sdn. Bhd. report to view the information.
Incorporation Date:
February 18, 2003
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Bio-Life Marketing Sdn. Bhd.
100%
Company Performance
Financial values in the chart are available after Mega Lifesciences Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
5.36%
Total operating revenue
5.36%
Operating profit (EBIT)
-9.47%
EBITDA
-8.46%
Net Profit (Loss) for the Period
-31.25%
Total assets
6.57%
Total equity
3.68%
Operating Profit Margin (ROS)
-0.83%
Net Profit Margin
-1.72%
Return on Equity (ROE)
-1.8%
Debt to Equity Ratio
1.39%
Quick Ratio
0.06%
Cash Ratio
-0.11%

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?